Cnbx Pharmaceuticals Inc (CNBK) Annual Balance Sheets

Annual · GAAP · USD millions
Access CNBK quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Cnbx Pharmaceuticals Inc's liquidity, leverage, and long-term financial structure.
Annual Report, GAAP in USD millions
ITEM
(Aug 31 2025)
(Aug 31 2024) (Aug 31 2023) (Aug 31 2022) (Aug 31 2021)
Assets
Cash & cash equivalent0.02
Cash & Short-term Investments0.00
Prepaid Expense And Other Assets Current0.00
Total Current Assets0.02
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent0.00
Total Assets0.02
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.05
Short-term Debt DE11.20
Other Liabilities, Current0.00
Total Current Liabilities2.51
Total Long-term Debt0.00
Due To A Related Party Current1.27
Total Liabilities2.51
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock22.72
Retained Earnings / Accumulated Deficit-25.27
Accumulated Other Comprehensive Income0.00
Other Equity0.00
Common Stockholder's Equity-2.50
Total Stockholder's Equity-2.50
Liabilities & Stockholder's Equity0.02
4 historic quarters locked

Sign in to unlock the full Cnbx Pharmaceuticals Inc balance sheet history.

About Cnbx Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-25-008736

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License